BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23211970)

  • 1. Structure-activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling.
    Lee IY; Gruber TD; Samuels A; Yun M; Nam B; Kang M; Crowley K; Winterroth B; Boshoff HI; Barry CE
    Bioorg Med Chem; 2013 Jan; 21(1):114-26. PubMed ID: 23211970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oriented development of antituberculotics: salicylanilides.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
    Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
    Paraskevopoulos G; Monteiro S; Vosátka R; Krátký M; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J
    Bioorg Med Chem; 2017 Feb; 25(4):1524-1532. PubMed ID: 28126437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
    Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
    Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
    Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
    Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains.
    Imramovský A; Vinsová J; Férriz JM; Dolezal R; Jampílek J; Kaustová J; Kunc F
    Bioorg Med Chem; 2009 May; 17(10):3572-9. PubMed ID: 19403314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.
    Baranyai Z; Krátký M; Vosátka R; Szabó E; Senoner Z; Dávid S; Stolaříková J; Vinšová J; Bősze S
    Eur J Med Chem; 2017 Jun; 133():152-173. PubMed ID: 28384546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
    Krátký M; Vinšová J; Stolaříková J
    Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
    Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J
    Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Palát K; Kaustová J
    Arch Pharm (Weinheim); 2007 May; 340(5):264-7. PubMed ID: 17516578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
    Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
    Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
    Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
    Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
    Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
    Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
    Gold B; Smith R; Nguyen Q; Roberts J; Ling Y; Lopez Quezada L; Somersan S; Warrier T; Little D; Pingle M; Zhang D; Ballinger E; Zimmerman M; Dartois V; Hanson P; Mitscher LA; Porubsky P; Rogers S; Schoenen FJ; Nathan C; Aubé J
    J Med Chem; 2016 Jul; 59(13):6027-44. PubMed ID: 27144688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
    Paraskevopoulos G; Krátký M; Mandíková J; Trejtnar F; Stolaříková J; Pávek P; Besra G; Vinšová J
    Bioorg Med Chem; 2015 Nov; 23(22):7292-301. PubMed ID: 26526729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation.
    Shalini ; Viljoen A; Kremer L; Kumar V
    Bioorg Med Chem Lett; 2018 May; 28(8):1309-1312. PubMed ID: 29551480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Oxo and 6-thio purine analogs as antimycobacterial agents.
    Pathak AK; Pathak V; Seitz LE; Suling WJ; Reynolds RC
    Bioorg Med Chem; 2013 Apr; 21(7):1685-95. PubMed ID: 23434367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and antitubercular activity of 3-amidophenols with 5-heteroatomic substitutions.
    Zhang NN; Tang YX; Qian L; Gao YM; Liu ZY; Zou ZL; Zhang TY; Yan M
    Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800277. PubMed ID: 30698293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents.
    Kang S; Kim YM; Jeon H; Park S; Seo MJ; Lee S; Park D; Nam J; Lee S; Nam K; Kim S; Kim J
    Eur J Med Chem; 2017 Aug; 136():420-427. PubMed ID: 28527405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages.
    Sorrentino F; Gonzalez del Rio R; Zheng X; Presa Matilla J; Torres Gomez P; Martinez Hoyos M; Perez Herran ME; Mendoza Losana A; Av-Gay Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):640-5. PubMed ID: 26503663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.